Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term sulodexide to prevent recurrent venous thromboembolism
2009-016923-77Phase 3Completed
- Sponsor
- Alfa Wassermann
- Start
- May 2010
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in venous thromboembolism (VTE) and deep vein thrombosis (DVT) comparing Sulodexide with Placebo (2 arms). Primary endpoint: Time to confirmed VTE recurrence. Started May 2010; status: completed.
02
Drugs
sulodexide
03
Conditions
venous thromboembolism (VTE)deep vein thrombosis (DVT)
Beyond the preview
Go deeper on 2009-016923-77.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016923-77.